Particle TherapyIndustry Overview
Global particle
therapy market is projected to reach USD 1,004 million by 2027 from USD 677
million in 2022, growing at a CAGR of 8.2% from 2022 to 2027.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137
Market growth is driven by factors such as growing adoption
of particle therapy in clinical trials and the increasing number of particle
therapy centers worldwide. Emerging markets are China India, Brazil, and South
Africa are showing lucrative growth opportunities to market.
Covid-19 Impact on Economic Scenario in Particle Therapy
Market
Globally, the outbreak of COVID-19 has impacted every aspect
of the medical device industry, including particle therapy devices. From region
to region, there is considerable variation in the management of particle
therapy procedures during the COVID-19 pandemic. The particle therapy market is
expected to be impacted due to the temporary postponement of various elective
surgeries as governments and authorities seek to ensure the availability of
resources for COVID-19 patients.
Particle Therapy Market Segmentation
Pediatric cancer defined for the largest share in the
particle therapy market by cancer type
Based on cancer type, the particle therapy market is
segmented into prostate cancer. pediatric cancer, lung cancer, breast cancer,
head & neck cancer, and other cancers. The pediatric cancer segment is
holds the largest share of 24.8% of the particle therapy market in 2021 with
CAGR of 10.4% during the forecast period.
Products such as cyclotron accounted for the largest
share in the particle therapy market by product type
Based on products & services, the particle therapy
market is segmented into products and services. In 2021, products are estimated
to account for the largest share of 78.6% of the particle therapy market.
Based on system, multi-room systems holds the largest
share in the particle therapy
Based on the system, the particle therapy market is
segmented into single-room and multi-room particle therapy systems. The
multi-room systems segment is expected to account for the largest share (67.8%)
of the particle therapy market.
Particle Therapy Regional Outlook
Key Companies Profile & Market Share Insights
Prominent players in the particle therapy market include
Varian Medical Systems, Inc. (US), IBA Worldwide (EU), Mevion Medical Systems
(US), Provision Healthcare, LLC (US), Sumitomo Heavy Industries, Ltd. (Japan),
Hitachi, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), Protom International,
Inc. (US), Advanced Oncotherapy PLC. (EU), and Danfysik A/S (Denmark)
IBA is one of the leading players in the particle
therapy market. Its Proton Therapy segment offers Proteus PLUS, a treatment
room solution, and Proteus ONE, a single-room cancer treatment solution.
Order
a free sample PDFof the Particle TherapyMarket Intelligence Study, published by MarketsandMarkets.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on
30,000 high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies’ revenues. Currently servicing 7500 customers worldwide including
80% of global Fortune 1000 companies as clients. Almost 75,000 top officers
across eight industries worldwide approach MarketsandMarkets™ for their
painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies, innovators, strategic players)
annually in high growth emerging segments. MarketsandMarkets™ is determined to
benefit more than 10,000 companies this year for their revenue planning and
help them take their innovations/disruptions early to the market by providing
them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and
market research platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper understanding of the unmet insights
along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
The Wall